Anusol is developed by Church & Dwight Company, Inc..

What development phase is Anusol in?

Anusol is FDA-approved (marketed).

Last reviewed 2026-04-20 · How we verify

Anusol

Church & Dwight Company, Inc. · FDA-approved active Small molecule Quality 2/100

At a glance

Generic name	Anusol
Also known as	Anusol Ointment (Zinc oxide, Bismuth subgallate, Balsam peru), Bismuth oxide)
Sponsor	Church & Dwight Company, Inc.
Modality	Small molecule
Therapeutic area	Other
Phase	FDA-approved

Approved indications

No approved indications tracked.

Common side effects

No common side effects on file.

Key clinical trials

Clinical Trial of Anusol Ointment for Symptom Relief in Patients With Haemorrhoids (PHASE3)
Effect of Low Dose Corticosteroids on Perioperative Markers of Thrombosis and Fibrinolysis in Total Knee Arthroplasty (PHASE4)

Primary sources

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.

Source	Used for
ClinicalTrials.gov	Trial enrolment, design, endpoints, results

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:

Anusol CI brief — competitive landscape report
Anusol updates RSS · CI watch RSS
Church & Dwight Company, Inc. portfolio CI